Network meta-analysis for health technology submissions worldwide: A report checklist for best practice

Network meta-analysis (NMA) is an accepted statistical method used to model the clinical- and cost-effectiveness of treatments in the absence of data from head-to-head randomised controlled trials (RCTs).1,2 In the fifth of our DRG investigative series, we assess submission guidelines by health technology assessment (HTA) bodies and suggest a reporting checklist for NMAs to support manufacturers in meeting the requirements for global technology appraisal.


We are part of Clarivate, a global leader in providing trusted insights and analytics to accelerate the pace of innovation.

Our Company
© DRG Abacus 2021